Livagen

Livagen is a tetrapeptide with the sequence KEDA or Lys-Glu-Asp-Ala. It is one of a number of small peptides developed in Russia in the late 1990s and early 2000s which have antiinflammatory and purported anti-aging effects, and are now widely sold over the internet as anti-aging products though with relatively limited evidence to support these claims.^{[1][2][3][4][5][6][7][8]}

PubChem CID

• 87919683

ChemSpider

• 57489559

FormulaC₁₈H₃₁N₅O₉

Molar mass461.472 g·mol⁻¹

Quick facts Identifiers, PubChem CID ...

Livagen

Identifiers
IUPAC name (4S)-5-[[(2S)-3-carboxy-1-[[(1S)-1-carboxyethyl]amino]-1-oxopropan-2-yl]amino]-4-[[(2S)-2,6-diaminohexanoyl]amino]-5-oxopentanoic acid
PubChem CID	87919683
ChemSpider	57489559
Chemical and physical data
Formula	C18H31N5O9
Molar mass	461.472 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N
InChI InChI=1S/C18H31N5O9/c1-9(18(31)32)21-17(30)12(8-14(26)27)23-16(29)11(5-6-13(24)25)22-15(28)10(20)4-2-3-7-19/h9-12H,2-8,19-20H2,1H3,(H,21,30)(H,22,28)(H,23,29)(H,24,25)(H,26,27)(H,31,32)/t9-,10-,11-,12-/m0/s1 Key:IKVDKWACACMDLR-BJDJZHNGSA-N

Close